Literature DB >> 11704881

Chemokines and central nervous system disorders.

W J Karpus1.   

Abstract

Chemokines and their receptors are large families of inflammatory molecules responsible for a number of biologic functions including the accumulation of leukocytes at tissue sites. Over the past 8 years, a number of studies have indicated a role for chemokines in the pathogenesis of CNS inflammatory diseases. This minireview provides a brief summary of our current knowledge of chemokines and CNS inflammatory diseases including experimental autoimmune encephalomyelitis, multiple sclerosis, virus-induced demyelinating diseases, Alzheimer's disease, and central nervous system bacterial-induced diseases.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11704881     DOI: 10.1080/135502801753248079

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   2.643


  70 in total

1.  Neutralization of macrophage inflammatory protein 2 (MIP-2) and MIP-1alpha attenuates neutrophil recruitment in the central nervous system during experimental bacterial meningitis.

Authors:  A Diab; H Abdalla; H L Li; F D Shi; J Zhu; B Höjberg; L Lindquist; B Wretlind; M Bakhiet; H Link
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

2.  Biphasic and regionally-restricted chemokine expression in the central nervous system in the Theiler's virus model of multiple sclerosis.

Authors:  P D Murray; K Krivacic; A Chernosky; T Wei; R M Ransohoff; M Rodriguez
Journal:  J Neurovirol       Date:  2000-05       Impact factor: 2.643

3.  Functional expression of the CXC-chemokine receptor-4/fusin on mouse microglial cells and astrocytes.

Authors:  S Tanabe; M Heesen; I Yoshizawa; M A Berman; Y Luo; C C Bleul; T A Springer; K Okuda; N Gerard; M E Dorf
Journal:  J Immunol       Date:  1997-07-15       Impact factor: 5.422

Review 4.  Chemokine receptor antagonism as a new therapy for multiple sclerosis.

Authors:  R M Ransohoff; K B Bacon
Journal:  Expert Opin Investig Drugs       Date:  2000-05       Impact factor: 6.206

5.  Leukocyte recruitment during onset of experimental allergic encephalomyelitis is CCR1 dependent.

Authors:  J B Rottman; A J Slavin; R Silva; H L Weiner; C G Gerard; W W Hancock
Journal:  Eur J Immunol       Date:  2000-08       Impact factor: 5.532

6.  Amyloid-beta induces chemokine secretion and monocyte migration across a human blood--brain barrier model.

Authors:  M Fiala; L Zhang; X Gan; B Sherry; D Taub; M C Graves; S Hama; D Way; M Weinand; M Witte; D Lorton; Y M Kuo; A E Roher
Journal:  Mol Med       Date:  1998-07       Impact factor: 6.354

7.  Identification and characterization of small molecule functional antagonists of the CCR1 chemokine receptor.

Authors:  J Hesselgesser; H P Ng; M Liang; W Zheng; K May; J G Bauman; S Monahan; I Islam; G P Wei; A Ghannam; D D Taub; M Rosser; R M Snider; M M Morrissey; H D Perez; R Horuk
Journal:  J Biol Chem       Date:  1998-06-19       Impact factor: 5.157

8.  Astrocyte expression of mRNA encoding cytokines IP-10 and JE/MCP-1 in experimental autoimmune encephalomyelitis.

Authors:  R M Ransohoff; T A Hamilton; M Tani; M H Stoler; H E Shick; J A Major; M L Estes; D M Thomas; V K Tuohy
Journal:  FASEB J       Date:  1993-04-01       Impact factor: 5.191

9.  Immunohistochemical study of the beta-chemokine receptors CCR3 and CCR5 and their ligands in normal and Alzheimer's disease brains.

Authors:  M Q Xia; S X Qin; L J Wu; C R Mackay; B T Hyman
Journal:  Am J Pathol       Date:  1998-07       Impact factor: 4.307

10.  Absence of monocyte chemoattractant protein 1 in mice leads to decreased local macrophage recruitment and antigen-specific T helper cell type 1 immune response in experimental autoimmune encephalomyelitis.

Authors:  D R Huang; J Wang; P Kivisakk; B J Rollins; R M Ransohoff
Journal:  J Exp Med       Date:  2001-03-19       Impact factor: 14.307

View more
  7 in total

1.  Relationship between inflammatory mediators, Aβ levels and ApoE genotype in Alzheimer disease.

Authors:  M Reale; M A Kamal; L Velluto; D Gambi; M Di Nicola; N H Greig
Journal:  Curr Alzheimer Res       Date:  2012-05       Impact factor: 3.498

Review 2.  Fractalkine (CX3CL1) and brain inflammation: Implications for HIV-1-associated dementia.

Authors:  R Cotter; C Williams; L Ryan; David Erichsen; A Lopez; H Peng; J Zheng
Journal:  J Neurovirol       Date:  2002-12       Impact factor: 2.643

3.  CX3CL1 (fractalkine) and CX3CR1 expression in myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis: kinetics and cellular origin.

Authors:  Dan Sunnemark; Sana Eltayeb; Maria Nilsson; Erik Wallström; Hans Lassmann; Tomas Olsson; Anna-Lena Berg; Anders Ericsson-Dahlstrand
Journal:  J Neuroinflammation       Date:  2005-07-29       Impact factor: 8.322

Review 4.  Analysis of leukocyte extravasation across the blood-brain barrier: conceptual and technical aspects.

Authors:  Melissa K Callahan; Richard M Ransohoff
Journal:  Curr Allergy Asthma Rep       Date:  2004-01       Impact factor: 4.919

5.  Systemic and local CC chemokines production in a murine model of Listeria monocytogenes infection.

Authors:  Marina Bubonja; Branka Wraber; Gordana Brumini; Ivana Gobin; Danijela Veljkovic; Maja Abram
Journal:  Mediators Inflamm       Date:  2006       Impact factor: 4.711

6.  Elevated expression of fractalkine (CX3CL1) and fractalkine receptor (CX3CR1) in the dorsal root ganglia and spinal cord in experimental autoimmune encephalomyelitis: implications in multiple sclerosis-induced neuropathic pain.

Authors:  Wenjun Zhu; Crystal Acosta; Brian MacNeil; Claudia Cortes; Howard Intrater; Yuewen Gong; Mike Namaka
Journal:  Biomed Res Int       Date:  2013-09-24       Impact factor: 3.411

7.  Modulation of viral replication in macrophages persistently infected with the DA strain of Theiler's murine encephalomyelitis virus.

Authors:  Stephane Steurbaut; Ellen Merckx; Bart Rombaut; Raf Vrijsen
Journal:  Virol J       Date:  2008-08-04       Impact factor: 4.099

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.